Health Condition 1: null- Oxytocin induced hypotension and tachycardia
Conditions
Interventions
Intervention1: Group P: Phenylephrine 100 μg in 1 ml volume will be injected before oxytocin administration
Control Intervention1: Group S: Normal saline 1 ml will be injected before oxytocin adminis
Sponsors
University College of Medical Sciences and Guru Teg Bahadur Hospital
Eligibility
Inclusion criteria
Inclusion criteria: • Healthy term pregnant patients undergoing elective caesarean section under spinal anaesthesia • Uncomplicated, singleton pregnancy
Exclusion criteria
Exclusion criteria: • Patients in active labour • Ruptured membranes • Known drug allergy to oxytocin • Maternal complications e.g. pre-eclampsia, diabetes mellitus, cardiovascular disease, cerebrovascular disease • Known risk factors for postpartum haemorrhage e.g. Multiple gestation, abnormal placentation, uterine fibroid, macrosomia, hydramnios, history of postpartum haemorrhage or uterine atony • Patients with absolute or relative contra-indications for spinal anaesthesia e.g. infection in lumbar area, coagulation abnormalities, autonomic neuropathy, spinal deformities, other neurological diseases or hypovolemia due to any cause
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peak changes in mean arterial pressure and heart rateTimepoint: Peak changes in mean arterial pressure and heart rate | — |
Secondary
| Measure | Time frame |
|---|---|
| a)Changes in systolic blood pressure and diastolic blood pressure b)Any complications observed Timepoint: a)Initial 3 minutes following oxytocin administration b)After delivery | — |
Countries
India
Contacts
Public ContactDr Medha Mohta
University College of Medical Sciences and Guru Teg Bahadur Hospital
Outcome results
None listed